Measurement of insulin resistance in chronic kidney disease

Current Opinion in Nephrology and Hypertension

Volumn 20, Issue 6, 2011, Pages 640-646

  Pham, Hien ^a   Utzschneider, Kristina M ^b   De Boer, Ian H ^a,c  

^a Kidney Research Institute   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

chronic kidney disease; insulin resistance

Indexed keywords

CALCITRIOL; GLUCOSE; INSULIN; TOLBUTAMIDE; VITAMIN D;

AMINO ACID METABOLISM; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMORBIDITY; GLOMERULUS FILTRATION RATE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GOLD STANDARD; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; KIDNEY CLEARANCE; MEASUREMENT; METABOLIC ACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SKELETAL MUSCLE;

CARDIOVASCULAR DISEASES; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; RENAL INSUFFICIENCY, CHRONIC;

EID: 80054732008     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32834b23c1     Document Type: Review

References (62)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298:2038-2047. (Pubitemid 350074801)
2. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9 (12 Suppl):S16-S23.
3. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
4. Siew ED, Ikizler TA. Determinants of insulin resistance and its effects on protein metabolism in patients with advanced chronic kidney disease. Contrib Nephrol 2008; 161:138-144.
5. Shinohara K, Shoji T, Emoto M, et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002; 13:1894-1900. (Pubitemid 34700615)
6. Howard G, O'Leary DH, Zaccaro D, et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996; 93:1809-1817.
7. Zethelius B, Lithell H, Hales CN, Berne C. Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp. Diabetologia 2005; 48:862-867. (Pubitemid 40767978)
8. Hedblad B, Nilsson P, Engstorm G, et al. Insulin resistance in nondiabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med 2002; 19:470-475. (Pubitemid 34639157)
9. Rutter MK, Meigs JB, Sullivan LM, et al. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 2005; 54:3252-3257. (Pubitemid 43334382)
10. Siew ED, Ikizler TA. Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease. Semin Dial 2010; 23:378-382.
11. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005; 365:1333-1346.
12. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993; 42:1663-1672. (Pubitemid 23318125)
13. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003; 46:3-19. (Pubitemid 36237741)
14. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008; 294:E15-E26.
15. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-E223. (Pubitemid 9249478)
16. Bergman RN. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 1989; 38:1512-1527. (Pubitemid 20006675)
17. Bergman RN, Hope ID, Yang YJ, et al. Assessment of insulin sensitivity in vivo: a critical review. Diabetes Metab Rev 1989; 5:411-429. (Pubitemid 19194684)
18. Bergman RN, Ider YZ, Bowden CR, et al. Quantitative estimation of insulin sensitivity. Am J Physiol 1979; 236:E667-E677. (Pubitemid 9220487)
19. Yang YJ, Youn JH, Bergman RN. Modified protocols improveinsulin sensitivity estimation using the minimal model. Am J Physiol 1987; 253:E595-E602.
20. Mari A. Assessment of insulin sensitivity with minimal model: role of model assumptions. Am J Physiol 1997; 272:E925-E934.
21. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22:1462-1470. (Pubitemid 29418240)
22. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23:295-301. (Pubitemid 30131733)
23. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419. (Pubitemid 15018832)
24. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27:1487-1495. (Pubitemid 38680001)
25. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85:2402-2410. (Pubitemid 32269192)
26. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23:57-63. (Pubitemid 30022895)
27. Emoto M, Nishizawa Y, Maekawa K, et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999; 22:818-822. (Pubitemid 29220786)
28. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000; 85:4426-4433. (Pubitemid 32157613)
29. DeFronzo RA, Alvestrand A, Smith D, et al. Insulin resistance in uremia. J Clin Invest 1981; 67:563-568. (Pubitemid 11141740)
30. DeFronzo RA. Pathogenesis of glucose intolerance in uremia. Metabolism 1978; 27 (12 Suppl 2):1866-1880.
31. Fliser D, Kielstein JT, Menne J. Insulin resistance and renal disease. Contrib Nephrol 2006; 151:203-211. (Pubitemid 44298233)
32. Menon V, Rudym D, Chandra P, et al. Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease. Clin J Am Soc Nephrol 2011; 6:7-13.
33. Kobayashi S, Maesato K, Moriya H, et al. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 2005; 45:275-280. (Pubitemid 40431052)
34. Nerpin E, Riserus U, Ingelsson E, et al. Insulin sensitivity measured with euglycemic clamp is independently associated with glomerularfiltration rate in a community-based cohort. Diabetes Care 2008; 31:1550-1555.
35. Chonchol M, Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 2007; 71:134-139. (Pubitemid 46094686)
36. Landau M, Kurella-Tamura M, Shlipak MG, et al.; for the Health, Aging and Body Composition Study. Correlates of insulin resistance in older individuals with and without kidney disease. Nephrol Dial Transplant 2011 [Epub ahead of print].
37. Capaldo B, Cianciaruso B, Napoli R, et al. Role of the splanchnic tissues in the pathogenesis of altered carbohydrate metabolism in patients with chronic renal failure. J Clin Endocrinol Metab 1990; 70:127-133.
38. Friedman JE, Dohm GL, Elton CW, et al. Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors. Am J Physiol 1991; 261 (1 Pt 1):E87-E94.
39. Trirogoff ML, Shintani A, Himmelfarb J, et al. Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3-4 chronic kidney disease patients. Am J Clin Nutr 2007; 86:1642-1648. (Pubitemid 350232178)
40. Allegra V, Mengozzi G, Martimbianco L, Vasile A. Glucose-induced insulin secretion in uremia: effects of aminophylline infusion and glucose loads. Kidney Int 1990; 38:1146-1150.
41. Kielstein JT, Zoccali C. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am J Kidney Dis 2005; 46:186-202. (Pubitemid 41040347)
42. Wilcken DE, Sim AS, Wang J, Wang XL. Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism. Mol Genet Metab 2007; 91:309-317; discussion 308. (Pubitemid 47043511)
43. Kalantar-Zadeh K, Mehrotra R, Fouque D, Kopple JD. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin Dial 2004; 17:455-465. (Pubitemid 40110431)
44. Mak RH. Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int 1998; 54:603-607. (Pubitemid 28357424)
45. de Boer IH. Vitamin D and glucose metabolism in chronic kidney disease. Curr Opin Nephrol Hypertens 2008; 17:566-572.
46. Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 1986; 119:84-90. (Pubitemid 16100711)
47. Quesada JM, Martin-Malo A, Santiago J, et al. Effect of calcitriol on insulin secretion in uraemia. Nephrol Dial Transplant 1990; 5:1013-1017.
48. Mak RH. Intravenous 1, 25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 1992; 41:1049-1054.
49. Mak RH. Amelioration of hypertension and insulin resistance by 1, 25-dihydroxycholecalciferol in hemodialysis patients. Pediatr Nephrol 1992; 6:345-348.
50. Allegra V, Luisetto G, Mengozzi G, et al. Glucose-induced insulin secretion in uremia: role of 1 alpha, 25(HO)2-vitamin D3. Nephron 1994; 68:41-47. (Pubitemid 24251186)
51. Lin SH, Lin YF, Lu KC, et al. Effects of intravenous calcitriol on lipid profiles and glucose tolerance in uraemic patients with secondary hyperparathyroid-ism. Clin Sci (Lond) 1994; 87:533-538.
52. Kautzky-Willer A, Pacini G, Barnas U, et al. Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 1995; 47:200-206.
53. Mak RH. 1, 25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia. Kidney Int 1998; 53:1353-1357.
54. Khajehdehi P, Taheri S. Effect of oral calcitriol pulse therapy on the lipid, calcium, and glucose homeostasis of hemodialysis-patients: its safety in a combination with oral calcium carbonate. J Ren Nutr 2003; 13:78-83. (Pubitemid 38368762)
55. Strozecki P, Kretowicz M, Odrowaz-Sypniewska G, Manitius J. The influence of intravenous 1, 25(OH)2D3 therapy on glucose metabolism in hemodialyzed patients with secondary hyperparathyroidism. Ren Fail 2004; 26:345-348. (Pubitemid 39167608)
56. DeFronzo RA, Tobin JD, Rowe JW, Andres R. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 1978; 62:425-435. (Pubitemid 8393313)
57. Mak RH, DeFronzo RA. Glucose and insulin metabolism in uremia. Nephron 1992; 61:377-382.
58. Rabkin R, Rubenstein AH, Colwell JA. Glomerular filtration and proximal tubular absorption of insulin 125 I. Am J Physiol 1972; 223:1093-1096.
59. Rabkin R, Ryan MP, Duckworth WC. The renal metabolism of insulin. Diabetologia 1984; 27:351-357. (Pubitemid 14044457)
60. Carone FA, Peterson DR. Hydrolysis and transport of small peptides by the proximal tubule. Am J Physiol 1980; 238:F151-F158. (Pubitemid 10118194)
61. Hung AM, Sundell MB, Egbert P, et al. A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patients. Clin J Am Soc Nephrol 2011; 6:767-774.
62. Ramos LF, Shintani A, Himmelfarb J, Ikizler TA. Determinants of plasma adiponectin levels in nondiabetic subjects with moderate to severe chronic kidney disease. J Ren Nutr 2009; 19:197-203.